---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-004412"
form_type: "8-K"
ticker: "OCEA"
cik: "0001869974"
company_name: "Ocean Biomedical, Inc."
filed_at: "2023-02-13T23:59:59+00:00"
generated_at: "2026-06-19T16:49:49.970928+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Aesther Healthcare increases backstop commitment to 8M shares; trust holds $110.9M

## Summary
- Maximum shares Vellar may purchase under backstop increased from 6M to 8M.
- Trust account held $110,914,254 as of Feb 10, 2023.
- Amendment to backstop agreement executed Feb 12, 2023, in connection with merger with Ocean Biomedical.
- No other changes to terms from prior agreement.

## SEC filing metadata
- accession: 0001493152-23-004412
- form_type: 8-K
- ticker: OCEA
- cik: 0001869974
- company_name: Ocean Biomedical, Inc.
- filed_at: 2023-02-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1869974/000149315223004412/0001493152-23-004412-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1869974/000149315223004412/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-004412
- JSON: https://secwatch.observer/filing/0001493152-23-004412.json
- Plain text: https://secwatch.observer/filing/0001493152-23-004412.txt

## Key facts
- Material Agreements
  Ocean Biomedical, Inc. amended Definitive A&R Backstop Agreement with Aesther, Ocean Biomedical, Vellar Opportunity Fund SPV LLC – Series 3 (effective 2023-02-12).
  - Action: amendment
  - Counterparty: Aesther, Ocean Biomedical, Vellar Opportunity Fund SPV LLC – Series 3
  - Effective: 2023-02-12
  source text: On February 12, 2023, Aesther, Ocean Biomedical and Vellar again amended and restated the Original Backstop Agreement (the “ Definitive A&R Backstop Agreement ”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1869974/000149315223004412/0001493152-23-004412-index.htm
- Material Agreements
  Ocean Biomedical, Inc. entered into Agreement and Plan of Merger with Aesther Healthcare Acquisition Corp., AHAC Merger Sub, Inc., Aesther Healthcare Sponsor, LLC, Ocean Biomedical, Inc., Dr. Chirinjeev Kathuria (effective 2022-08-31).
  - Action: entry
  - Agreement: merger
  - Counterparty: Aesther Healthcare Acquisition Corp., AHAC Merger Sub, Inc., Aesther Healthcare Sponsor, LLC, Ocean Biomedical, Inc., Dr. Chirinjeev Kathuria
  - Effective: 2022-08-31
  source text: On August 31, 2022, Aesther Healthcare Acquisition Corp., a Delaware corporation (“ Aesther ”) entered into an Agreement and Plan of Merger by and among Aesther, AHAC Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Aesther (“ Merger Sub ”), Aesther Healthcare Sponsor, LLC, Aesther’s sponsor (the “ Sponsor ”), in its capacity as purchaser representative, Ocean Biomedical, Inc., a Delaware corporation (“ Ocean Biomedical ”), and Dr. Chirinjeev Kathuria, in his capacity as seller representative (as may be amended and/or restated from time to time, the “ Merger Agreement ”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1869974/000149315223004412/0001493152-23-004412-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.